ValuEngine upgraded shares of HCA Holdings, Inc. (NYSE:HCA) from a hold rating to a buy rating in a research report sent to investors on Monday morning.

Other equities analysts have also issued reports about the stock. BidaskClub lowered shares of HCA Holdings from a sell rating to a strong sell rating in a report on Saturday, August 5th. Zacks Investment Research downgraded shares of HCA Holdings from a buy rating to a hold rating in a research note on Friday, July 14th. KeyCorp restated a buy rating and set a $95.00 target price on shares of HCA Holdings in a report on Thursday, September 7th. Citigroup Inc. lowered their target price on HCA Holdings from $89.00 to $87.00 and set a neutral rating for the company in a report on Wednesday, July 26th. Finally, Leerink Swann raised HCA Holdings from a market perform rating to an outperform rating and increased their target price for the company from $92.00 to $100.00 in a research report on Tuesday, June 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the company. The company has a consensus rating of Buy and a consensus target price of $92.88.

Shares of HCA Holdings (HCA) traded down 0.48% on Monday, hitting $79.54. 148,524 shares of the company traded hands. The firm has a market capitalization of $28.73 billion, a P/E ratio of 10.66 and a beta of 0.62. HCA Holdings has a 1-year low of $67.00 and a 1-year high of $91.03. The firm’s 50-day moving average is $78.33 and its 200 day moving average is $82.80.

HCA Holdings (NYSE:HCA) last posted its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period last year, the business posted $1.66 EPS. On average, analysts anticipate that HCA Holdings will post $7.18 earnings per share for the current fiscal year.

WARNING: “HCA Holdings, Inc. (HCA) Upgraded to Buy by ValuEngine” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/03/hca-holdings-inc-hca-upgraded-to-buy-by-valuengine.html.

In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $79.87, for a total value of $171,720.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In the last three months, insiders have sold 6,450 shares of company stock worth $529,309. 2.90% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Holdings by 14.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after acquiring an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in HCA Holdings by 35.1% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after acquiring an additional 320 shares during the last quarter. Atlantic Trust LLC purchased a new position in HCA Holdings in the 2nd quarter worth $118,000. Lee Financial Co acquired a new stake in HCA Holdings during the 2nd quarter worth about $125,000. Finally, Acrospire Investment Management LLC lifted its position in HCA Holdings by 14.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after acquiring an additional 200 shares during the period. 73.77% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.